GENELUX CORPORATION Fair Value Adjustment of Warrants
GENELUX CORPORATION (GNLX) reported Fair Value Adjustment of Warrants of $3.15 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-11-14
- GENELUX CORPORATION fair value adjustment of warrants for the quarter ending 2023-09-30 was $42.00K.
- GENELUX CORPORATION fair value adjustment of warrants for the quarter ending 2023-06-30 was $0.00.
- GENELUX CORPORATION fair value adjustment of warrants for the quarter ending 2023-03-31 was $3.11M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month |
|---|---|---|---|
| 2023-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $42.00K derived: sum of 2 quarters · filed 2023-11-14 | $3.15M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.11M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.11M 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |